A rare neurological disease is Sage’s last, best hope after failures in depression

In 2010, neuroscientist and former Eli Lilly research leader Steve Paul started a company that he hoped would spark a revolution in drug discovery, built …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Fresh from rebrand, Spyre Therapeutics raises $180M as it steers TLA1 program to clinic

Spyre Therapeutics is pulling in $180 million in a private placement just a couple of weeks after it rebranded from Aeglea BioTherapeutics. Spyre is selling

December 9, 2023

The Impact of Private Equity Consolidation in Healthcare

Austin Walters, Managing Partner at SpringTide Ventures On a brisk 2023 October morning at St. Elizabeth’s Medical Center in Boston, Sungida Rashid and her husband Nabil

October 7, 2024

The findings from Alnylam’s highly anticipated readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. On top of today’s

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.